Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Value Fund L. P. Biotechnology currently holds 16,000 shares of PIERIS PHARMACEUTICALS, INC. (PIRS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Value Fund L. P. Biotechnology has been a net seller of PIRS stock. They have purchased $83.9M and sold $268.8M worth of shares.
Value Fund L. P. Biotechnology's most recent insider trade was on Jun 18, 2024, when they sold 16,000 shares at $0.00 per share.
Value Fund L. P. Biotechnology serves as Executive at PIERIS PHARMACEUTICALS, INC. (PIRS). They have executed 257 insider transactions totaling $352.7M over their tenure at the company.
Value Fund L. P. Biotechnology holds the position of Executive at PIERIS PHARMACEUTICALS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Value Fund L. P. Biotechnology has shown a selling trading pattern, with $83.9M in total purchases and $268.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Value Fund L. P. Biotechnology was on Nov 11, 2020, when they sold $79.6M worth of FPRX shares. This transaction involved 3,941,214 shares at $20.19 per share.
Value Fund L. P. Biotechnology currently owns 16,000 shares of PIERIS PHARMACEUTICALS, INC. (PIRS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Value Fund L. P. Biotechnology's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Value Fund L. P. Biotechnology has 257 Form 4 filings on record as an insider at PIERIS PHARMACEUTICALS, INC..
Set alerts for Value Fund L. P. Biotechnology and 40,000+ other insiders.